Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Cancers|January 2, 2019
Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal CancerAndrea Dalbeni, Chiara Ciccarese, Michele Bevilacqua, et al.
European Urology Open Science|July 11, 2026
The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint InhibitorsRoberto Iacovelli, Chiara Ciccarese, Daniela Arduini, et al.
Therapeutic Advances in Medical Oncology|March 3, 2022
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinibSara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, et al.
Clinical Genitourinary Cancer|November 19, 2018
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian RegionMarco Maruzzo, Umberto Basso, Eugenio Borsatti, et al.
The Oncologist|June 22, 2014
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxomaFilippo Pietrantonio, Claudia Maggi, Giuseppe Fanetti, et al.
Life (Basel, Switzerland)|January 28, 2026
Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for SurgeryOr Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
Urologic Oncology|March 23, 2026
Patient-derived organoids in renal cell carcinoma: A review of methodologies and applicationsFilippo Gavi, Giuseppe Pallotta, Maria Chiara Sighinolfi, et al.
Cancers|July 12, 2025
Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes?Francesco Pio Bizzarri, Marco Campetella, Pierluigi Russo, et al.
Pathology Oncology Research : POR|July 12, 2017
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign OutcomeFrancesco Massari, Chiara Ciccarese, Ondrej Hes, et al.
BJU International|October 10, 2025
A novel comprehensive cancer genome profiling for non-metastatic prostate cancer: study protocol with FPG500 to detect actionable alterations representative of progressive diseaseMaria Chiara Sighinolfi, Giuseppe Pallotta, Simone Assumma, et al.
Pageof 23